Pretransplant, Th17 dominant alloreactivity in highly sensitized kidney transplant candidates.

Th17 cells alloreactivity highly sensitized mixed leukocyte reaction sensitization transplantation

Journal

Frontiers in transplantation
ISSN: 2813-2440
Titre abrégé: Front Transplant
Pays: Switzerland
ID NLM: 9918573988006676

Informations de publication

Date de publication:
2024
Historique:
received: 10 11 2023
accepted: 21 03 2024
medline: 12 7 2024
pubmed: 12 7 2024
entrez: 12 7 2024
Statut: epublish

Résumé

Sensitization to donor human leukocyte antigen (HLA) molecules prior to transplantation is a significant risk factor for delayed access to transplantation and to long-term outcomes. Memory T cells and their cytokines play a pivotal role in shaping immune responses, thereby increasing the risk of allograft rejection among highly sensitized patients. This study aims to elucidate the precise contribution of different CD4 Stimulation of peripheral blood mononuclear cells (PBMC) with various polyclonal stimulating agents to assess non-specific immune responses revealed that HS patients exhibit elevated immune reactivity even before kidney transplantation, compared to non-sensitized (NS) patients. HS patients' PBMC displayed higher frequencies of CD4 These results provide an assessment of pretransplant alloreactive T cell subsets in highly sensitized patients and emphasize the significance of Th17 cells in alloimmune responses. These findings hold promise for the development of treatment strategies tailored to sensitized kidney transplant recipients, with potential clinical implications.

Identifiants

pubmed: 38993777
doi: 10.3389/frtra.2024.1336563
pmc: PMC11235243
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1336563

Informations de copyright

© 2024 Negi, Rutman, Saw, Paraskevas and Tchervenkov.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Auteurs

Sarita Negi (S)

Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montréal, QC, Canada.
Human Islet Transplantation Laboratory, McGill University Health Centre, Montréal, QC, Canada.

Alissa K Rutman (AK)

Department of Medicine, McGill University, Montréal, QC, Canada.

Chee Loong Saw (CL)

HLA Laboratory, Division of Hematology, McGill University Health Centre, Montréal, QC, Canada.

Steven Paraskevas (S)

Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montréal, QC, Canada.
Human Islet Transplantation Laboratory, McGill University Health Centre, Montréal, QC, Canada.
Department of Surgery, McGill University, Montréal, QC, Canada.
Division of General Surgery and Multi-Organ Transplant Program, Department of Surgery, McGill University Health Centre, Montréal, QC, Canada.

Jean Tchervenkov (J)

Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montréal, QC, Canada.
Department of Surgery, McGill University, Montréal, QC, Canada.
Division of General Surgery and Multi-Organ Transplant Program, Department of Surgery, McGill University Health Centre, Montréal, QC, Canada.

Classifications MeSH